Inhalation Sciences announces extraordinary shareholder meeting

• Inhalation Sciences will hold an extraordinary general meeting on Aug. 18, 2026, to vote on a financing agreement of up to SEK 4 million.
• The meeting will consider approval of a SEK 4 million convertible credit facility with Tellus Equity, JEQ Capital, Thalor Capital, running to March 31, 2027.
• Shareholders will also vote on a directed issue of 8,800,000 TO4 warrants to the lenders as compensation under the facility.
• The proposals include authorizing the board to carry out related share issues, including potential loan conversion at SEK 0.29 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhalation Sciences Sweden AB published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.